2Noh J Y, Asari T, Hamada N, et al. Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves' disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations [ J ]. Clin Endocrinol (Oxf), 2001,54 : 651-654.
3Sera N, Ashizawa K, Ando T, et al. Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease[J]. Thyroid,2000,10:595-599.
4Gunton J E, Stiel J, Clifton-Bligh P, et al. Prevalence of positive anti-neutrophil cytoplasmic antibody(ANCA) in patients receiving anti-thyroid medication [J]. Eur J Endocrinol, 2000,142 : 587.
5Wada N, Mukai M, Kohno M, et al. Prevalence of serum anti-myeloperoxidase antineutruphil cytoplasmic antibodies(MPO-ANCA) in patients with Graves' disease treated with propylthiouracil and thiamazole [ J ]. Endocr J, 2002,49 :329-334.
6Sato H, Hattori M, Fujieda M, et al. High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves' disease treated with propylthiouracil [ J ]. J Clin Endocrinol Metab,2000,85:4270-4273.
7Winters M J, Hurley R M, Lirenman D S. ANCA-positive glomendonephritis and IgA nephropathy in a patient on propylthiouracil[J]. Pediatr Nephrol, 2002,17 : 257-260.
8Poomthavom P, Mahachoklertwattana P, Tapaneya-Olarn W, et al. Antineutrophilic cytoplasmic antibody-positive systemic vasculitis associated with propylthiouracil therapy:report of 2 children with Graves' disease[J]. J Med Assoc Thai, 2002,85 : 295-301.
9Kawasaki Y, Suzuki T, Sike T, et al. A pediatric case of myeloperoxidase-antineutrophil cytoplasmic antibody (ANC A)-related crescentic glomerulonephritis associated with propylthiouracil treatmant for Graves' disease [ J ]. Neppon Jinzo Gakkai Shi,1998,40:612-617.
10Makiyama Y, Ito M, Akiyama F, et al. Myeloperoxidaseantineutrophil cytoplasmic antibody positive alveolar hemorrhage during propylthiouracil therapy for hyperthyroidism[J]. Nihon Kokyuki Gakkai Zasshi,2000,38:201-205.
